Sodium intake, ACE inhibition, and progression to ESRD

Journal of the American Society of Nephrology

Volumn 23, Issue 1, 2012, Pages 165-173

  Vegter, Stefan ^a,b   Perna, Annalisa ^c   Postma, Maarten J ^a,b   Navis, Gerjan ^b   Remuzzi, Giuseppe ^c,d   Ruggenenti, Piero ^c,d  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIURETIC AGENT; RAMIPRIL; SODIUM;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDIUM SODIUM DIET; PRIORITY JOURNAL; PROTEINURIA; SODIUM EXCRETION; SODIUM INTAKE; SODIUM RESTRICTION; SODIUM URINE LEVEL; URINARY EXCRETION;

EID: 84855597182     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011040430     Document Type: Article

References (43)

1. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia): Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349: 1857-1863, 1997
2. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G: Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354: 359-364, 1999 (Pubitemid 29355751)
3. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G: Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy. Lancet 352: 1252-1256, 1998 (Pubitemid 28470337)
4. Ruggenenti P, Perna A, Remuzzi G GISEN Group Investigators: Retarding progression of chronic renal disease: The neglected issue of residual proteinuria. Kidney Int 63: 2254-2261, 2003 (Pubitemid 36605839)
5. Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK, Perna A, Remuzzi G: Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 19: 1213-1224, 2008
6. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S RENAAL Study Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869, 2001
7. Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G: Angiotensin converting enzyme insertion/deletion polymorphismand renoprotection in diabetic and nondiabetic nephropathies. Clin J Am Soc Nephrol 3: 1511-1525, 2008
8. Navis G, de Jong PE, Donker AJ, van der Hem GK, de Zeeuw D: Moderate sodium restriction in hypertensive subjects: Renal effects of ACE-inhibition. Kidney Int 31: 815-819, 1987 (Pubitemid 17025915)
9. Buter H, Hemmelder MH, Navis G, de Jong PE, de Zeeuw D: The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant 13: 1682-1685, 1998 (Pubitemid 28306794)
10. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G: Effects of dietary sodiumand hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 19: 999-1007, 2008
11. Ekinci EI, Thomas G, Thomas D, Johnson C, Macisaac RJ, Houlihan CA, Finch S, Panagiotopoulos S, O'Callaghan C, Jerums G: Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake. Diabetes Care 32: 1398-1403, 2009
12. Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, Navis G, Laverman GD HOlland NEphrology STudy Group: Moderate dietary sodium restriction added to angio-tensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: Randomised controlled trial. BMJ 343: d4366, 2011
13. Fabris B, Jackson B, Johnston CI: Salt blocks the renal benefits of ramipril in diabetic hypertensive rats. Hypertension 17: 497-503, 1991
14. Allen TJ, Waldron MJ, Casley D, Jerums G, Cooper ME: Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes 46: 19-24, 1997
15. Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D: Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in ratswith established adriamycin nephrosis. Clin Sci (Lond) 90: 393-401, 1996 (Pubitemid 26149407)
16. Kreutz R, Kovacevic L, Schulz A, Rothermund L, Ketteler M, Paul M: Effect of high NaCl diet on spontaneous hypertension in a genetic rat model with reduced nephron number. J Hypertens 18: 777-782, 2000 (Pubitemid 30406751)
17. De'Oliveira JM, Price DA, Fisher ND, Allan DR, McKnight JA, Williams GH, Hollenberg NK: Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int 52: 771-777, 1997 (Pubitemid 27402378)
18. Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, De Nicola L: Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 24: 296-301, 1998 (Pubitemid 28108269)
19. Ruggenenti P, Perna A, Loriga G, Ganeva M, Ene-Iordache B, Turturro M, Lesti M, Perticucci E, Chakarski IN, Leonardis D, Garini G, Sessa A, Basile C, Alpa M, Scanziani R, Sorba G, Zoccali C, Remuzzi G REIN-2 Study Group: Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): Multicentre, randomised controlled trial. Lancet 365: 939-946, 2005 (Pubitemid 41071427)
20. Epstein M: Aldosterone blockade: An emerging strategy for abrogating progressive renal disease. Am J Med 119: 912-919, 2006
21. Lakkis J, Lu WX, Weir MR: RAAS escape: A real clinical entity that may be important in the progression of cardiovascular and renal disease. Curr Hypertens Rep 5: 408-417, 2003
22. Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH: Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia 47: 1936-1939, 2004 (Pubitemid 40110201)
23. Shiigai T, Shichiri M: Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease. Am J Kidney Dis 37: 477-483, 2001 (Pubitemid 32195285)
24. du Cailar G, Ribstein J, Mimran A: Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 15: 222-229, 2002 (Pubitemid 34226186)
25. Houlihan CA, Allen TJ, Baxter AL, Panangiotopoulos S, Casley DJ, Cooper ME, Jerums G: A low-sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care 25: 663-671, 2002 (Pubitemid 41071184)
26. Krikken JA, Lely AT, Bakker SJ, Navis G: The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 71: 260-265, 2007 (Pubitemid 46160927)
27. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA: Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: A randomized control trial. Hypertension 46: 308-312, 2005 (Pubitemid 41099162)
28. Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ, de Zeeuw D, de Jong PE PREVEND Study Group: Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 256: 324-330, 2004 (Pubitemid 39304344)
29. Krikken JA, Laverman GD, Navis G: Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr Opin Nephrol Hypertens 18: 531-538, 2009
30. Largo R, Gómez-Garre D, Soto K, Marrón B, Blanco J, Gazapo RM, Plaza JJ, Egido J: Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 33: 732-739, 1999 (Pubitemid 29091657)
31. National Kidney Foundation: Guideline 1: Goals of antihypertensive therapy in CKD. Am J Kidney Dis 43: S65-S73, 2004
32. Vennegoor MA: Salt restriction and practical aspects to improve compliance. J Ren Nutr 19: 63-68, 2009
33. Gerdts E, Lund-Johansen P, Omvik P: Reproducibility of salt sensitivity testing using a dietary approach in essential hypertension. J Hum Hypertens 13: 375-384, 1999 (Pubitemid 29286956)
34. Mazouz H, Kacso I, Ghazali A, El Esper N, Moriniere P, Makdassi R, Hardy P, Westeel PF, Achard JM, Pruna A, Fournier A: Risk factors of renal failure progression two years prior to dialysis. Clin Nephrol 51: 355-366, 1999 (Pubitemid 29261695)
35. Wolfe RA, Strawderman RL: Logical and statistical fallacies in the use of Cox regression models. Am J Kidney Dis 27: 124-129, 1996 (Pubitemid 26017460)
36. Frost CD, Law MR, Wald NJ: By how much does dietary salt reduction lower blood pressure? II - Analysis of observational data within populations. BMJ 302: 815-818, 1991
37. De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, Strippoli M, Casino F, Giannattasio M, Petrarulo F, Virgilio M, Laraia E, Di Iorio BR, Savica V, Conte G TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group: Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention. Kidney Int 69: 538-545, 2006 (Pubitemid 43164447)
38. Intersalt Cooperative Research Group: Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 297: 319-328, 1988
39. Flack JM, Grimm RH Jr, Staffileno BA, Dnsc, Elmer P, Yunis C, Hedquist L, Dudley A: New salt-sensitivity metrics: Variability-adjusted blood pressure change and the urinary sodium-to-creatinine ratio. Ethn Dis 12: 10-19, 2002 (Pubitemid 34477390)
40. Rizopoulos D: JM: An R package for the joint modelling of longitudinal and time-to-event data. J Stat Softw 35: 1-33, 2010
41. Fox J, Laughton CD: Cox Proportional-Hazards Regression for Survival Data. An R and S-PLUS Companion to Applied Regression, Thousand Oaks, CA, Sage Publications Inc, 2002
42. Duenhas MR, Draibe SA, Avesani CM, Sesso R, Cuppari L: Influence of renal function on spontaneous dietary intake and on nutritional status of chronic renal insufficiency patients. Eur J Clin Nutr 57: 1473-1478, 2003 (Pubitemid 37407141)
43. Venables WN, Ripley BD: Modern Applied Statistics with S, New York, Springer, 2002